✉news HealthMedicine first seen 3 d ago, last 3 d ago, peak #37
New Approach Urged for Clinical Trial Patient Enrollment
Original: A New Approach to Clinical Trial Planning: How Mid-Market and Emerging Pharma Can Take Greater Control of Patient Enrollment
A trade publication outlines a new approach to clinical trial planning aimed at helping mid-market and emerging pharmaceutical companies take greater control of patient enrollment. The piece argues that smaller drug developers, which often lack the scale and resources of large pharma, can improve enrollment planning to keep trials on schedule and reduce costly delays.
Why now: Patient enrollment remains a leading cause of clinical trial delays, making planning strategies a timely topic for smaller pharma firms.
Applied Clinical Trialsmid-market pharmaemerging pharmaceutical companies
Evidence
- A New Approach to Clinical Trial Planning: How Mid-Market and Emerging Pharma Can Take Greater Control of Patient Enrollment · Applied Clinical Trials Online
API: https://socialmediatrends-api.osmike.com/v1/trends/2292459